Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Olaparib and bevacizumab in front-line maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?
Links
DOI
PubMed
Journal
Journal of Gynecologic Oncology